Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine XR in schizophrenia patients switched from other antipsychotics
NCT02142556Phase 3Completed
- Sponsor
- Tri-Service General Hospital
- Start
- Nov 2008
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of quetiapine in schizophrenia, sponsored by Tri-Service General Hospital. Started Nov 2008; status: completed.
02
Drugs
quetiapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT02142556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02142556.